CN Stock MarketDetailed Quotes

Chongqing Pharscin Pharmaceutical (002907)

Watchlist
  • 13.95
  • +0.02+0.14%
Market Closed Apr 30 15:00 CST
5.83BMarket Cap101.09P/E (TTM)

Chongqing Pharscin Pharmaceutical (002907) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Otolaryngology medication267.52M32.34%
Digestive system medication190.97M23.09%
Mental nervous system medication150.73M18.22%
Pharmaceutical commerce139.71M16.89%
Other areas of medication60.07M7.26%
Other business11.93M1.44%
Hormones and endocrine regulation drugs5.48M0.66%
Pharmaceutical retail726.33K0.09%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical industry674.78M81.58%
Pharmaceutical commerce139.71M16.89%
Other business11.93M1.44%
Pharmaceutical retail726.33K0.09%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Southwest area371.69M44.94%
East China region150.24M18.16%
Central China147.5M17.83%
South China60.74M7.34%
North China49.97M6.04%
Northeast area27.07M3.27%
Northwest region19.87M2.40%
Overseas59.48K0.01%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More